AQUESTIVE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.09 USD | -6.08% |
|
-12.22% | +52.97% |
| May. 10 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
| May. 08 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Other Pharmaceuticals | -6.08% | -12.22% | +52.97% | +56.85% | -38.69% | 281M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- AQST Stock
- Charts Aquestive Therapeutics, Inc.
- Comparison Chart